This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Doulgas E Berg: Innovator in Genetic Engineering
Introduction
Doulgas E Berg is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of genetic engineering, particularly through his innovative work on DNA transposons.
Latest Patents
Doulgas E Berg holds a patent for the DNA transposon TN5SUPF in plasmid pBRG1310. This small, novel transposon is useful for mutagenesis and sequencing DNAs cloned in phage .lambda. The patent discloses a transposon that comprises a transposon having at each terminus a segment of 19 nucleotides selected from the group consisting of the O-end and I-end sequences of Tn5. Additionally, it includes at least one restriction enzyme site positioned less than 20 nucleotides distant from each terminal segment, along with a supF amber-suppressor tRNA gene insert.
Career Highlights
Doulgas E Berg is affiliated with Washington University, where he continues to advance research in genetic engineering. His work has paved the way for new methodologies in DNA manipulation and analysis.
Collaborations
He has collaborated with notable colleagues such as Suhas H Phadnis and Henry V Huang, contributing to a rich environment of innovation and research.
Conclusion
Doulgas E Berg's contributions to the field of genetic engineering through his patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence advancements in DNA technology.